Gene drive makes mosquitoes malaria-resistant in Tanzanian lab test

A genetic technology called a gene drive has shown promise in preventing malaria transmission by mosquitoes during lab tests in Tanzania. Researchers modified local mosquitoes to produce antimalarial proteins, demonstrating effective inhibition of parasites from infected children. The findings suggest the approach could work in the field if released.

Scientists have advanced a strategy to combat malaria using gene drives, which bias inheritance to spread specific genes through mosquito populations. In a secure lab at the Ifakara Health Institute in Tanzania, researchers led by George Christophides from Imperial College London and Dickson Lwetoijera modified Anopheles gambiae mosquitoes, the primary malaria vector in the region.

The gene drive incorporates genes for two small proteins—one from honeybees and one from the African clawed frog—that disrupt malaria parasite development. These proteins are produced after the mosquito feeds on blood, thanks to linkage with a digestive enzyme gene, and are secreted into the gut. Earlier work by Christophides in 2022 identified these proteins using outdated lab strains, but the new tests used fresh parasites from infected children and local mosquitoes.

Results confirmed robust suppression of parasite growth and reliable gene copying, even though the drive components were kept separate to prevent uncontrolled spread. "So we are now able to say that this technology could work in the field," Christophides stated.

The next phase involves releasing modified mosquitoes on an island in Lake Victoria to observe their wild behavior. The team is consulting local communities and conducting risk assessments, with Lwetoijera noting, "To date, the political and public support has remained positive."

Christophides envisions the drive eliminating malaria in areas dominated by A. gambiae, calling it "a game-changing technology" that "may turn the tide." Unlike current modified mosquito releases requiring massive ongoing efforts, gene drives could self-propagate. Other teams are developing similar tools for malaria and pest control, with the study published in Nature (DOI: 10.1038/s41586-025-09685-6).

Liittyvät artikkelit

Illustration of UC San Diego researchers' CRISPR pPro-MobV system spreading through bacterial biofilms to disable antibiotic resistance genes in a lab setting.
AI:n luoma kuva

UC San Diego researchers describe a gene-drive-like CRISPR system designed to reduce antibiotic resistance in bacteria

Raportoinut AI AI:n luoma kuva Faktatarkistettu

Researchers at the University of California San Diego report they have developed a second-generation CRISPR-based “Pro-Active Genetics” system, called pPro-MobV, that is designed to spread between bacteria and disable antibiotic-resistance genes, including inside hard-to-treat biofilms.

Researchers have discovered a protein called Aurora-related kinase 1 (ARK1) that is vital for the malaria parasite's cell division. Disabling ARK1 in experiments halted the parasite's ability to replicate in both human and mosquito hosts. The finding, published in Nature Communications, highlights a potential target for new antimalarial drugs.

Raportoinut AI

Scientists in Brazil and Peru are using machine learning for early outbreak predictions and Wolbachia-infected mosquitoes to curb dengue fever, amid rising cases fueled by climate change. In Lima, a 2024 epidemic overwhelmed hospitals, prompting adaptations now informing regional strategies. These efforts offer models as subtropical U.S. areas report local transmissions.

University of Utah researchers report that iron-rich hemozoin crystals inside the malaria parasite Plasmodium falciparum move through the parasite’s digestive compartment because reactions involving hydrogen peroxide at the crystal surface generate chemical propulsion. The work, published in Proceedings of the National Academy of Sciences, links a long-observed phenomenon to peroxide chemistry and could point to new antimalarial drug strategies and ideas for engineered micro- and nanoscale devices.

Raportoinut AI

At October's Pandemic Research Alliance Symposium, researcher Wei Zhao presented an innovative concept using CRISPR to combat influenza. The idea targets the virus's replication process, potentially halting its spread. This development highlights ongoing efforts in gene-editing research against relentless flu strains.

Researchers in Israel have used CRISPR gene editing to deactivate a gene that produces bitter chemicals in grapefruit, potentially making the fruit more appealing to consumers. This innovation could expand the market for citrus and combat the devastating citrus greening disease by enabling cold-hardy, edible varieties. The approach aims to shift citrus farming to temperate regions like northern Europe.

Raportoinut AI

A 20-year experiment cloning mice has revealed that clones develop significantly more genetic mutations than naturally reproduced mice, accumulating to fatal levels after multiple generations. Researchers led by Teruhiko Wakayama at Yamanashi University in Japan found over 70 mutations per clone generation on average, three times higher than in controls. The findings, published in Nature Communications, raise concerns for applications in farming, conservation and de-extinction efforts.

 

 

 

Tämä verkkosivusto käyttää evästeitä

Käytämme evästeitä analyysiä varten parantaaksemme sivustoamme. Lue tietosuojakäytäntömme tietosuojakäytäntö lisätietoja varten.
Hylkää